130 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 3 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
ENO1Enolase 1Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Liver cancer: 1.30e-8
Glioma: 2.12e-4
Expressed in all
ENO2Enolase 2Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Renal cancer: 7.89e-11
Liver cancer: 5.15e-4
Colorectal cancer: 6.96e-4
Tissue enriched
ENO3Enolase 3Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol
Colorectal cancer: 7.33e-4
Tissue enriched
ENO4Enolase family member 4Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
ENOSF1Enolase superfamily member 1Enzymes
Predicted intracellular proteins
Breast cancer: 2.27e-4
Mixed
ETNPPLEthanolamine-phosphate phospho-lyaseEnzymes
Predicted intracellular proteins
NucleusGlioma: 1.31e-4
Group enriched
FAHD1Fumarylacetoacetate hydrolase domain containing 1Enzymes
Predicted intracellular proteins
Nucleus
Mitochondria
Renal cancer: 2.80e-14
Colorectal cancer: 8.27e-4
Expressed in all
FASNFatty acid synthaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Cervical cancer: 1.42e-5
Renal cancer: 7.16e-5
Expressed in all
FECHFerrochelataseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 2.38e-10
Expressed in all
FHFumarate hydrataseCancer-related genes
Citric acid cycle related proteins
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 2.76e-7
Expressed in all
FTCDFormimidoyltransferase cyclodeaminaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol
Pancreatic cancer: 6.78e-5
Liver cancer: 1.70e-4
Renal cancer: 5.78e-4
Group enriched
GAD1Glutamate decarboxylase 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
VesiclesCervical cancer: 7.31e-4
Endometrial cancer: 8.61e-4
Tissue enriched
GAD2Glutamate decarboxylase 2Enzymes
Predicted intracellular proteins
Tissue enriched
GADL1Glutamate decarboxylase like 1Enzymes
Predicted intracellular proteins
Plasma membrane
Cytosol
Tissue enhanced
GGCXGamma-glutamyl carboxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Endometrial cancer: 1.82e-6
Expressed in all
GLO1Glyoxalase ICancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol
Liver cancer: 5.21e-4
Expressed in all
GLULGlutamate-ammonia ligaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Mitochondria
Cytosol
Breast cancer: 4.81e-4
Expressed in all
GMDSGDP-mannose 4,6-dehydrataseEnzymes
Predicted intracellular proteins
Endometrial cancer: 5.89e-4
Renal cancer: 5.93e-4
Mixed
GUCY1A2Guanylate cyclase 1 soluble subunit alpha 2Enzymes
FDA approved drug targets
Predicted intracellular proteins
Renal cancer: 3.02e-5
Tissue enhanced
GUCY1A3Guanylate cyclase 1 soluble subunit alphaDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleusLung cancer: 2.38e-4
Testis cancer: 3.59e-4
Renal cancer: 7.59e-4
Tissue enhanced
GUCY1B3Guanylate cyclase 1 soluble subunit betaEnzymes
Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 2.42e-4
Testis cancer: 3.23e-4
Expressed in all
GUCY2CGuanylate cyclase 2CDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
VesiclesLiver cancer: 1.37e-5
Group enriched
GUCY2DGuanylate cyclase 2D, retinalDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
GUCY2FGuanylate cyclase 2F, retinalEnzymes
Plasma proteins
Predicted membrane proteins
Not detected
HACD13-hydroxyacyl-CoA dehydratase 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HACD23-hydroxyacyl-CoA dehydratase 2Enzymes
Predicted membrane proteins
Pancreatic cancer: 9.59e-5
Expressed in all
HACD33-hydroxyacyl-CoA dehydratase 3Enzymes
Predicted membrane proteins
Nuclear membrane
Endoplasmic reticulum
Mitochondria
Cytosol
Renal cancer: 3.09e-5
Expressed in all
HACD43-hydroxyacyl-CoA dehydratase 4Enzymes
Predicted membrane proteins
Ovarian cancer: 3.14e-4
Renal cancer: 6.77e-4
Mixed
HADHAHydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunitDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 3.68e-5
Expressed in all
HALHistidine ammonia-lyaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
CytosolGroup enriched
HCCSHolocytochrome c synthaseDisease related genes
Enzymes
Potential drug targets
Predicted secreted proteins
MitochondriaRenal cancer: 6.17e-8
Liver cancer: 1.35e-5
Breast cancer: 8.69e-5
Expressed in all
HDCHistidine decarboxylaseEnzymes
Predicted intracellular proteins
Tissue enhanced
HMGCL3-hydroxymethyl-3-methylglutaryl-CoA lyaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 5.07e-8
Colorectal cancer: 7.67e-4
Expressed in all
HMGCLL13-hydroxymethyl-3-methylglutaryl-CoA lyase like 1Enzymes
Predicted intracellular proteins
Tissue enhanced
HOGA14-hydroxy-2-oxoglutarate aldolase 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 9.08e-4
Tissue enhanced
HSD17B4Hydroxysteroid 17-beta dehydrogenase 4Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
PeroxisomesRenal cancer: 6.31e-6
Colorectal cancer: 1.33e-4
Expressed in all
KYAT1Kynurenine aminotransferase 1Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Mixed
KYAT3Kynurenine aminotransferase 3Enzymes
Predicted intracellular proteins
Nucleoli
Cytosol
Renal cancer: 5.02e-6
Breast cancer: 3.19e-5
Head and neck cancer: 1.86e-4
Ovarian cancer: 2.80e-4
Expressed in all
L3HYPDHTrans-L-3-hydroxyproline dehydrataseEnzymes
Predicted intracellular proteins
VesiclesRenal cancer: 1.72e-9
Expressed in all
LTC4SLeukotriene C4 synthaseDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Tissue enhanced
MLYCDMalonyl-CoA decarboxylaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 2.61e-7
Mixed
MOCS1Molybdenum cofactor synthesis 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol
Cervical cancer: 1.07e-5
Pancreatic cancer: 6.07e-5
Mixed
MVDMevalonate diphosphate decarboxylaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Cell Junctions
Cytosol
Endometrial cancer: 2.17e-4
Expressed in all
NAXDNAD(P)HX dehydrataseEnzymes
Predicted intracellular proteins
Renal cancer: 4.63e-5
Endometrial cancer: 3.15e-4
Expressed in all
NEIL1Nei like DNA glycosylase 1Enzymes
Plasma proteins
Predicted intracellular proteins
NucleoplasmPancreatic cancer: 2.09e-4
Expressed in all
NEIL2Nei like DNA glycosylase 2Enzymes
Predicted intracellular proteins
Nucleoplasm
Vesicles
Expressed in all
NEIL3Nei like DNA glycosylase 3Enzymes
Plasma proteins
Predicted intracellular proteins
NucleoplasmLung cancer: 1.16e-4
Endometrial cancer: 5.45e-4
Mixed
NPLN-acetylneuraminate pyruvate lyaseEnzymes
Predicted intracellular proteins
Vesicles
Plasma membrane
Renal cancer: 6.63e-4
Liver cancer: 8.05e-4
Mixed
NPR1Natriuretic peptide receptor 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Nucleus
Nucleoli
Plasma membrane
Pancreatic cancer: 2.49e-4
Endometrial cancer: 3.97e-4
Tissue enhanced
NPR2Natriuretic peptide receptor 2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
« prev | Page of 3 | next »